Zhixing Automotive Technology (01274.HK): Proposed adoption of a share award scheme
On May 23, Gelonghui | Zhixing Auto Technology (01274.HK) issued an announcement. On May 23, 2024, the board of directors resolved to recommend the adoption of the Company's H share award plan.
Laikai Pharmaceutical-B plans to adopt a share award plan
Laikai Pharmaceutical-B (02105) issued an announcement. The board of directors of the company has resolved to approve the recommendation to adopt a share award plan, subject to shareholders' approval at the annual shareholders' meeting. According to the announcement, the purpose of the share award program is to attract and retain participants who have contributed significantly to the long-term growth and success of the Group, recognize and reward their past contributions to the Group, provide participants with an opportunity to obtain the company's exclusive rights and encourage participants to make further contributions to the company, and strive to enhance the value of the company and its shares in order to meet the overall interests of the company and its shareholders.
Laikai Pharmaceutical-B (02105.HK) proposes to adopt a share award scheme
Gelonghui, May 21丨Laikai Pharmaceutical-B (02105.HK) announced that the board of directors has resolved to approve the proposed adoption of the share award plan, subject to shareholders' approval at the annual shareholders' meeting. The purpose of the share award scheme is to attract and retain participants who have contributed significantly to the long-term growth and success of the Group, recognize and reward their past contributions to the Group, provide participants with an opportunity to obtain the company's exclusive rights and encourage participants to further contribute to the company, and strive to enhance the value of the company and its shares to meet the overall interests of the company and its shareholders. The share award program provides companies with a flexible approach to
Adopted shares (301122.SZ): 2023 equity distribution, 10 distributions of 4 yuan, share registration date May 20
On May 13, Ge Longhui announced the adoption of shares (301122.SZ). The company's 2023 equity distribution plan is to distribute RMB 4.000000 in cash (tax included) to all shareholders for every 10 shares based on the company's current total share capital of 122,245,658 shares. The share registration date for this equity distribution is May 20, 2024, and the ex-dividend date is May 21, 2024.
Huanlong Holdings (02260) adopts share award scheme
Huanlong Holdings (02260) issued an announcement. The company adopted a share award plan on May 9, 2024, and the directors...
Guangshang Culture Holdings (08082): Approval of the share award scheme
According to Zhitong Finance App News, Guangshang Culture Holdings (08082) issued an announcement. According to the voting results of the special shareholders' meeting and section 23.02 (1) of the GEM listing rules, ordinary resolutions approving the adoption of the share award plan; and terminating the current share option plan and adopting a new share option plan were officially passed by voting.
Caina Technology's (SZSE:301122) Shareholders Have More To Worry About Than Only Soft Earnings
The subdued market reaction suggests that Caina Technology Co., Ltd.'s (SZSE:301122) recent earnings didn't contain any surprises. Our analysis suggests that along with soft profit numbers, investors
Adopted shares (301122.SZ): Net profit of 2,5454 million yuan in the first quarter increased 57.73% year-on-year
On April 24, Ge Longhui shares (301122.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 111 million yuan, up 65.52% year on year; net profit attributable to shareholders of listed companies was 25.454 million yuan, up 57.73% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 177.03.98 million yuan, up 114.87% year on year; basic earnings per share were 0.20 yuan.
Adopted shares (301122.SZ): 2023 net profit of 113 million yuan, plan to distribute 4 yuan
On April 18, Ge Longhui shares (301122.SZ) announced the 2023 annual report. In 2023, the company achieved operating income of 410 million yuan, a year-on-year decrease of 11.82%; net profit attributable to shareholders of listed companies was 113 million yuan, a year-on-year decrease of 30.46%; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 84.858 million yuan, a year-on-year decrease of 38.98%; basic earnings per share were 0.92 yuan; it is planned to distribute a cash dividend of 4.00 yuan (tax included) to all shareholders for every 10 shares.
Yihe Holdings (01662.HK) adopts share award scheme
Gelonghui, April 17, 丨 Yihe Holdings (01662.HK) announced that on April 17, 2024, the board of directors approved the adoption of a share award scheme, that is, the plan. The purpose of the program is to recognize and reward the contributions of eligible participants to the Group's growth and development and provide incentives to eligible participants to retain such eligible participants so that the Group can continue to operate and develop and attract suitable personnel to further develop the Group.
Guofu Innovation proposes to adopt a share award scheme
Guofu Innovation (00290) announced that the company conditionally adopted a share option plan at the company's annual shareholders' meeting held on September 2, 2021 to motivate selected participants and reward their contributions to the group. As of the date of this announcement, the Company has granted 91.5 million share options to the Group's directors and employees, and there are still 30,800 share options that can be further granted under the share option plan. In order to recognize and recognize the contributions that eligible participants (including but not limited to Group employees) have made or may make to the Group, and to provide rewards to eligible participants, the Company suggests adopting a share award scheme. Based on share awards
Guofu Innovation (00290.HK) proposes to adopt a share award scheme
Gelonghui, April 11, 丨 Guofu Innovation (00290.HK) announced that in order to recognize and recognize the contributions that eligible participants (including but not limited to group employees) have made or may make to the Group and provide rewards to eligible participants, the company proposes to adopt a share award scheme. According to the share award scheme, which is valid for ten (10) years from the date of adoption, the award shares will be paid by (i) allocating and issuing new shares to the trustee; and/or (ii) the trustee buys existing shares in the market.
Adopt shares (301122.SZ), the majority shareholder, CITIC Prudential's bulk transaction to reduce holdings by 2.4326 million shares
Adopting the share (301122.SZ) announcement, CITIC Prudential Life Insurance Co., Ltd., the shareholder of the company holding more than 5% of the shares...
US FDA Puts Caina's Plastic Syringes on Import Alert List
The US Food and Drug Administration included Jiangsu Caina Medical's (SHE:301122) plastic syringes on its import alert list due to possible device failures, according to an FDA notice on April 3. The
Jutao Offshore Oil Services (03303) adopts share award scheme
Zhitong Finance App News, Jutao Offshore Oil Service (03303) issued an announcement, and the board of directors resolved to adopt the share award plan. The plan will only be disbursed from existing shares and will not involve the issuance of any new shares, and is valid for ten years. The purpose is to: recognize and reward the contributions of several eligible participants to the Group's growth and development, and provide them with incentives to retain their continued effectiveness in the Group's operations and development; attract suitable talents for the further development of the Group; better coordinate the interests of managers, employees and shareholders; and effectively motivate the Group's management team and key employees, thereby promoting the long-term development of the Group and achieving shares
Greentown Management Holdings (09979) grants 3.5 million bonus shares under the adopted share award scheme
Greentown Management Holdings (09979) issued an announcement. On March 22, 2024, the company's board of directors based on the board's salary...
Investors Could Be Concerned With Caina Technology's (SZSE:301122) Returns On Capital
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world, we'd like to see a company investing more capital into its business and ideally t
Hongxin C&D (09930) Adopts Restricted Share Award Scheme and Proposes Adoption of Share Option Plan
Zhitong Finance App News, Hongxin Construction and Development (09930) announced that on March 12, 2024, the board of directors resolved and approved the adoption of a restricted share award scheme and recommended the adoption of a share option plan. The directors believe that the Group's continued success is closely linked to the commitment and effort of employees. Adopting a restricted share award scheme and recommending adoption of a share option scheme can be used as an incentive to encourage employees to make more contributions to the Group. With the approval of the board of directors, the restricted shares granted under the restricted share award scheme shall not exceed 3.5% of the total number of shares issued by the company on the day the restricted share award scheme is approved and adopted by the board of directors.
Bishengyuan (00926.HK) proposes to adopt a share option plan
Gelonghui, March 8, 丨 Bishengyuan (00926.HK) announced that on March 8, 2024, the board of directors of the company approved the proposal to adopt a share option plan. The plan will constitute a share plan under Chapter 17 of the Hong Kong Stock Exchange Limited Securities Listing Rules.
Adopted shares (301122.SZ): Some of the subsidiary's products have passed the US FDA review
On March 8, Ge Longhui Co., Ltd. (301122.SZ) announced that Jiangsu Adona Medical Technology Co., Ltd., a wholly-owned subsidiary, recently received a notice from the US Food and Drug Administration to adopt medical safety slide blood collection needle products that have passed the US FDA's review and officially obtained permission to enter the US market. Up to now, the company and its subsidiaries have 29 FDA-registered products.
No Data